Your browser is no longer supported. Please, upgrade your browser.
LLY Eli Lilly and Company monthly Stock Chart
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E24.74 EPS (ttm)6.03 Insider Own11.80% Shs Outstand908.20M Perf Week-2.45%
Market Cap144.15B Forward P/E18.90 EPS next Y7.90 Insider Trans-2.71% Shs Float954.97M Perf Month-4.77%
Income5.53B PEG2.02 EPS next Q1.59 Inst Own79.70% Short Float0.91% Perf Quarter5.48%
Sales23.09B P/S6.24 EPS this Y54.10% Inst Trans0.34% Short Ratio1.91 Perf Half Y25.74%
Book/sh3.39 P/B44.01 EPS next Y16.07% ROA14.10% Target Price156.00 Perf Year26.99%
Cash/sh1.84 P/C81.10 EPS next 5Y12.24% ROE186.80% 52W Range101.36 - 164.90 Perf YTD13.53%
Dividend2.96 P/FCF104.81 EPS past 5Y17.40% ROI24.60% 52W High-9.51% Beta0.26
Dividend %1.98% Quick Ratio0.90 Sales past 5Y2.60% Gross Margin79.20% 52W Low47.21% ATR4.08
Employees33625 Current Ratio1.10 Sales Q/Q15.10% Oper. Margin12.90% RSI (14)45.48 Volatility2.39% 2.71%
OptionableYes Debt/Eq5.60 EPS Q/Q180.20% Profit Margin24.00% Rel Volume1.01 Prev Close150.71
ShortableYes LT Debt/Eq4.54 EarningsApr 23 BMO Payout44.10% Avg Volume4.54M Price149.21
Recom2.40 SMA20-2.99% SMA50-1.00% SMA20014.51% Volume4,577,271 Change-1.00%
Apr-21-20Downgrade UBS Buy → Neutral $157 → $158
Apr-09-20Downgrade Morgan Stanley Overweight → Equal-Weight $148
Feb-06-20Initiated Mizuho Neutral
Dec-18-19Upgrade Morgan Stanley Equal-Weight → Overweight $116 → $150
Oct-17-19Resumed BofA/Merrill Buy $133
May-28-19Initiated Goldman Buy
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Sep-26-18Resumed JP Morgan Overweight $117
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jun-06-20 07:41AM  
Jun-05-20 01:22PM  
10:42AM  
09:09AM  
Jun-04-20 10:19AM  
08:45AM  
Jun-03-20 06:18PM  
12:51PM  
12:37PM  
10:00AM  
09:52AM  
06:45AM  
06:45AM  
06:13AM  
Jun-02-20 03:41PM  
12:27PM  
11:32AM  
11:00AM  
10:53AM  
10:22AM  
10:18AM  
09:16AM  
08:00AM  
07:00AM  
12:19AM  
Jun-01-20 04:45PM  
04:19PM  
03:40PM  
03:38PM  
03:28PM  
03:02PM  
02:59PM  
02:05PM  
12:12PM  
11:45AM  
11:42AM  
11:09AM  
10:47AM  
10:03AM  
09:52AM  
09:02AM  
08:06AM  
08:05AM  
07:26AM  
06:45AM  
06:38AM  
06:30AM  
May-31-20 07:30PM  
07:30PM  
05:32PM  
May-30-20 11:45AM  
11:42AM  
May-29-20 09:07PM  
12:23PM  
09:40AM  
09:37AM  
08:47AM  
08:17AM  
May-28-20 08:52PM  
07:17PM  
06:10PM  
01:33PM  
10:40AM  
May-27-20 11:45AM  
11:12AM  
08:13AM  
05:01AM  
05:00AM  
May-26-20 05:51PM  
03:26PM  
11:05AM  
11:04AM  
10:11AM  
09:37AM  
08:00AM  
06:45AM  
05:37AM  
May-23-20 11:30AM  
May-22-20 11:37AM  
06:07AM  
May-21-20 04:03PM  
02:24PM  
11:30AM  
May-20-20 09:03AM  
07:59AM  
06:42AM  
May-19-20 12:46PM  
09:00AM  
May-18-20 10:00AM  
May-17-20 12:27PM  
May-15-20 03:51PM  
02:08PM  
10:45AM  
10:18AM  
May-14-20 11:00PM  
07:37PM  
02:01PM  
11:51AM  
10:00AM  
09:34AM  
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It offers endocrinology products for diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and paediatric growth conditions. The company also provides neuroscience products for treating depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; migraine and episodic cluster headache; attention-deficit hyperactivity disorder; and schizophrenia. In addition, it offers immunology products for the treatment of rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and products to treat erectile dysfunction and benign prostatic hyperplasia. Eli Lilly and Company primarily has collaborations with Incyte Corporation; Pfizer Inc.; Dicerna Pharmaceuticals, Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; Duke Clinical Research Institute for the prevention of chronic heart failure and mortality after an acute myocardial infarction; and AbCellera Biologics Inc., as well as an agreement with Junshi Biosciences to co-develop therapeutic antibodies for the potential prevention and treatment of COVID-19, the disease caused by the SARS-CoV-2 novel coronavirus. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LILLY ENDOWMENT INC10% OwnerApr 27Sale163.6012,6632,071,715112,197,641Apr 28 12:21 PM
LILLY ENDOWMENT INC10% OwnerApr 24Sale162.47220,00035,743,218112,210,304Apr 27 02:36 PM
LILLY ENDOWMENT INC10% OwnerApr 23Sale160.12230,00036,826,587112,430,304Apr 27 10:39 AM
Shah Aarti S.SVP & CIOApr 14Sale150.002,000300,00019,087Apr 16 11:23 AM
LILLY ENDOWMENT INC10% OwnerApr 09Sale145.42230,00033,445,542112,660,304Apr 13 02:43 PM
LILLY ENDOWMENT INC10% OwnerApr 07Sale143.20172,31524,676,281112,890,304Apr 08 12:49 PM
LILLY ENDOWMENT INC10% OwnerApr 06Sale142.7315,9622,278,322113,062,619Apr 07 11:40 AM
LILLY ENDOWMENT INC10% OwnerApr 03Sale143.1926,7233,826,493113,078,581Apr 06 02:42 PM
LILLY ENDOWMENT INC10% OwnerApr 02Sale140.78166,03823,374,654113,105,304Apr 03 12:42 PM
LILLY ENDOWMENT INC10% OwnerMar 31Sale140.0738,9625,457,474113,271,342Apr 01 01:47 PM
Fry Stephen FSVP, HR & DiversityMar 30Sale134.3014,6571,968,434107,415Mar 31 11:50 AM
LILLY ENDOWMENT INC10% OwnerMar 30Sale139.11210,00029,213,559113,310,304Mar 31 04:03 PM
Norton JohnaSenior VP, Global QualityMar 16Sale131.004,727619,23717,674Mar 18 10:44 AM
O'Neill MylesSVP & Pres., Mfg. OperationsMar 04Sale140.1525,0003,503,7508,469Mar 06 10:46 AM
Zakrowski Donald AChief Accounting OfficerMar 02Sale128.003,700473,6004,740Mar 03 03:27 PM
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.00970162Feb 18 02:57 PM
LILLY ENDOWMENT INC10% OwnerFeb 05Sale146.61200,00029,321,808113,520,304Feb 06 02:27 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0016,317045,623Feb 04 03:59 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0069,3500226,755Feb 04 03:54 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0013,0550113,266Feb 04 03:47 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.004,896025,166Feb 04 03:44 PM
LILLY ENDOWMENT INC10% OwnerJan 13Sale138.92205,00028,478,495113,720,304Jan 14 01:37 PM
LILLY ENDOWMENT INC10% OwnerJan 10Sale138.00210,00028,979,013113,925,304Jan 13 11:00 AM
LILLY ENDOWMENT INC10% OwnerJan 09Sale135.79220,00029,874,729114,135,304Jan 10 01:45 PM
LILLY ENDOWMENT INC10% OwnerJan 08Sale133.32172,65023,018,105114,355,304Jan 09 02:04 PM
LILLY ENDOWMENT INC10% OwnerJan 07Sale132.9032,6454,338,579114,527,954Jan 08 11:33 AM
LILLY ENDOWMENT INC10% OwnerDec 20Sale132.9019,7052,618,812114,560,599Dec 23 09:48 AM
LILLY ENDOWMENT INC10% OwnerDec 18Sale129.29220,00028,443,848114,580,304Dec 19 02:36 PM
LILLY ENDOWMENT INC10% OwnerDec 17Sale125.69215,00027,023,552114,800,304Dec 18 11:31 AM
LILLY ENDOWMENT INC10% OwnerDec 09Sale119.7010,9621,312,151115,015,304Dec 10 11:49 AM
O'Neill MylesSVP & Pres., Mfg. OperationsDec 06Sale120.0025,0003,000,00033,414Dec 10 11:56 AM
Zulueta Alfonso GSVP & President, Lilly Int'lDec 06Sale120.004,500540,00029,306Dec 09 04:37 PM
LILLY ENDOWMENT INC10% OwnerDec 06Sale120.15194,03823,313,498115,026,266Dec 09 09:51 AM
LILLY ENDOWMENT INC10% OwnerDec 04Sale118.52210,00024,890,040115,220,304Dec 05 01:31 PM
LILLY ENDOWMENT INC10% OwnerNov 27Sale117.5148,9535,752,257115,430,304Dec 02 01:40 PM
LILLY ENDOWMENT INC10% OwnerNov 26Sale117.8156,7296,683,470115,479,257Nov 27 10:40 AM
LILLY ENDOWMENT INC10% OwnerNov 25Sale117.60109,31812,855,797115,535,986Nov 26 11:19 AM
LILLY ENDOWMENT INC10% OwnerNov 22Sale116.25251,73629,263,596115,645,304Nov 25 04:29 PM
LILLY ENDOWMENT INC10% OwnerNov 21Sale115.14108,26412,465,506115,897,040Nov 22 10:56 AM
LILLY ENDOWMENT INC10% OwnerNov 19Sale115.06205,00023,586,776116,005,304Nov 20 10:17 AM
LILLY ENDOWMENT INC10% OwnerNov 18Sale114.0010,5981,208,172116,210,304Nov 19 12:00 PM
LILLY ENDOWMENT INC10% OwnerNov 12Sale114.007,981909,841116,220,902Nov 13 01:53 PM
LILLY ENDOWMENT INC10% OwnerNov 11Sale114.0710011,407116,228,883Nov 12 01:12 PM
LILLY ENDOWMENT INC10% OwnerNov 07Sale114.3740045,749116,228,983Nov 08 10:35 AM
LILLY ENDOWMENT INC10% OwnerNov 06Sale114.05173,91819,835,000116,229,383Nov 07 11:03 AM
LILLY ENDOWMENT INC10% OwnerNov 04Sale114.047,003798,608116,403,301Nov 05 01:18 PM
LILLY ENDOWMENT INC10% OwnerOct 31Sale114.00190,00021,659,646116,410,304Nov 01 10:37 AM
White Anne E.SVP & Pres-Lilly OncologyOct 25Buy108.841,000108,84022,043Oct 28 03:11 PM
Smiley Joshua LSVP and CFOOct 25Buy107.5992999,95131,524Oct 28 03:06 PM
Skovronsky DanielSVP, CSO, and Pres. LRLOct 25Buy108.615,000543,05075,818Oct 28 03:00 PM
Ricks David APresident & CEOOct 25Buy108.384,615500,174157,405Oct 25 12:13 PM
TAI JACKSON PDirectorOct 24Buy107.491,861200,03956,440Oct 25 12:10 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 20Sale117.004,500526,50033,806Sep 23 03:54 PM
LILLY ENDOWMENT INC10% OwnerSep 20Sale116.37210,00024,437,726116,600,304Sep 23 01:33 PM
Fry Stephen FSVP, HR & DiversitySep 05Sale115.009,4521,086,980100,211Sep 09 12:12 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 03Sale112.9119,5002,201,74538,306Sep 04 03:09 PM
Smiley Joshua LSVP and CFOJul 15Buy108.4718520,06730,595Jul 15 03:46 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39404,036Jul 08 03:57 PM